Otsuka Pakistan Limited resumes production after completing its annual maintenance, with shares rising 4.3%. Routine shutdown ensures operational efficiency and market reliability.
Otsuka Pakistan Limited has resumed production at its manufacturing facility following the completion of planned annual ...
Police investigate medical negligence after two dialysis patients died at Haripad hospital, raising concerns about safety ...
The Indore contaminated water crisis, where sewage leaked into drinking water, sickening hundreds and causing deaths, ...
Eisai serves as the lead of LEQEMBI development and regulatory submissions globally with Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision-making ...
BioArctic AB's (publ) partner Eisai announced today that the Biologics License Application (BLA) for the subcutaneous formulation (subcutaneous autoinjector: SC-AI) of Leqembi (lecanemab) for ...
Fresenius Kabi, an Operating Company of Fresenius, and a leading provider of essential medicines and medical technologies, ...
BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that the Biologics License Application (BLA) for the subcutaneous formulation ...
Being diagnosed with high blood pressure is important, as it is one of the biggest risk factors for heart attacks and strokes ...
Interim data from 14 patients with progressive lung cancers in dose-escalation cohorts of systemically administered Olvi-Vec-primed ...
A phase 1 study to evaluate safety, tolerability, bioavailability, pharmacokinetics, and weight loss of GLP-1/GLP-2 dual agonist, PG-102, ...
“We are encouraged by the emerging data from our lung cancer programs, where systemically delivered Olvi-Vec continues to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback